A first-of-its-kind study has revealed that millions of Americans could benefit from psilocybin therapy if approved by the U.S.
Drug Science and University College London (UCL) are joining forces in a new collaboration that seeks to address concerns over the therapy component of MDMA-assisted psychotherapy...
On August 9 the U.S
Awakn Life Sciences has entered into a new collaboration with Graft Polymer to advance its New Chemical Entity (NCE) programme, developing novel molecules for innovative addiction...
Last month, the Dutch State Commission on MDMA released its report advising the Government to allow access to MDMA-Assisted Therapy (MDMA-AT) for people living with PTSD.
Shortwave Life Sciences, previously Psych Capital, has received a positive patent report from the PCT confirming its mucoadhesive buccal film as a novel and inventive drug...
A new study from MedUni Vienna has identified three new variants of MDMA as promising alternatives for safer use in a controlled psychotherapeutic setting.
An advisory body to the U.S
The war in Ukraine brings suffering and trauma, which naturally leads to cases of post-traumatic stress disorder (PTSD) among soldiers and civilians.
Psychologists, therapists and counsellors play a fundamental role in treating common mental health disorders such as anxiety and depression.
An emerging body of evidence is showing psychedelics as promising treatments for mental health conditions, and psychiatry needs to be prepared for their arrival, say researchers.
Psychedelics started 2024 with a bang, and the innovative medicines are continuing to gain traction as the year progresses.
